Venous thromboembolism in breast cancer patients receiving cyclin-dependent kinase inhibitors.

被引：1
|
作者：
Gervaso, Lorenzo
Montero, Alberto J.
Jia, Xuefei
Khorana, Alok A.
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[2] Cleveland Clin, NSABP Fdn, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e18184
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18184
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Venous thromboembolism in breast cancer patients receiving cyclin-dependent kinase inhibitors
    Gervaso, Lorenzo
    Montero, Alberto J.
    Jia, Xuefei
    Khorana, Alok A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (01) : 162 - 168
  • [2] Cyclin-dependent kinase 4/6 inhibitors (CDKI)-associated venous thromboembolism in patients with hormone receptor (HR)-positive breast cancer
    Thein, K. Z.
    Htut, T. Win
    Myat, Y. M.
    Han, M. M.
    Oo, T. H.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1284 - S1284
  • [3] Substituted aminobenzimidazole pyrimidines as cyclin-dependent kinase inhibitors.
    Verma, SK
    Reddy, S
    Nagarathnam, D
    Shao, JX
    Zhang, L
    Zhao, J
    Wang, YM
    Li, T
    Mull, E
    Wang, CG
    Zhu, QM
    Altieri, M
    Dang, TTA
    Jordan, J
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U949 - U949
  • [4] INHIBITORS OF CYCLIN-DEPENDENT KINASE AND CANCER
    BIGGS, JR
    KRAFT, AS
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 1995, 73 (10): : 509 - 514
  • [5] Thromboembolic disease associated with cyclin-dependent kinase inhibitors in patients with breast cancer
    Lopez Robles, J.
    Adoamnei, E.
    Cacho Lavin, D.
    Diaz PedRoche, C.
    Coma Salvans, E.
    Pamies Ramon, M. I.
    Verdejo, F. J. G.
    Cejuela, M.
    Garcia-Adrian, S.
    Portero, B. O.
    Garrido Fernandez, A.
    Salvador Coloma, C.
    Mendiola, J.
    Munoz Martin, A. J.
    Sanchez Canovas, M.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1117 - S1117
  • [6] Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer
    Takahashi, Kaori
    Uozumi, Ryuji
    Mukohara, Toru
    Hayashida, Tetsu
    Iwabe, Midori
    Iihara, Hirotoshi
    Kusuhara-Mamishin, Kanako
    Kitagawa, Yuko
    Tsuchiya, Masami
    Kitahora, Mika
    Nagayama, Aiko
    Kosaka, Shinkichi
    Asano-Niwa, Yoshimi
    Seki, Tomoko
    Ohnuki, Koji
    Suzuki, Akio
    Ono, Fumiko
    Futamura, Manabu
    Kawazoe, Hitoshi
    Nakamura, Tomonori
    [J]. ONCOLOGIST, 2024, 29 (06): : e741 - e749
  • [7] Cyclin-Dependent Kinase 4/6 Inhibitors Against Breast Cancer
    Hassan, Mohammed Al-Kassim
    Ates-Alagoz, Zeynep
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2023, 23 (04) : 412 - 428
  • [8] Cyclin-dependent kinase 4/6 inhibitors in breast cancer therapy
    Migliaccio, Ilenia
    Di Leo, Angelo
    Malorni, Luca
    [J]. CURRENT OPINION IN ONCOLOGY, 2014, 26 (06) : 568 - 575
  • [9] Cyclin-dependent kinase inhibitors for treating cancer
    Toogood, PL
    [J]. MEDICINAL RESEARCH REVIEWS, 2001, 21 (06) : 487 - 498
  • [10] Cyclin-dependent kinase inhibitors and human cancer
    Kamb, A
    [J]. CYCLIN DEPENDENT KINASE (CDK) INHIBITORS, 1998, 227 : 139 - 148
12345